Previous communications have demonstrated the advantages of inhalation of ethyl iodide in treating certain diseases (1, 2). Two hundred patients with epidermophytosis, tinea capitis, tinea favosa, monilia infections, cryptococcosis epidermica, blastomycosis and other mycotic infections have been treated by means of inhalations of ethyl iodide. Many of these patients, treated for a period of years with unsatisfactory results by the methods hitherto available, have shown striking improvement and even complete recovery. No reports of the therapeutic use of ethyl iodide by other investigators were available in the literature. The purpose of the present investigation was to study the elimination of ethyl iodide after inhalation in order to establish the optimum dosage and frequency of treatment, and to gain knowledge concerning the mechanism of its action.
Previous communications have demonstrated the advantages of inhalation of ethyl iodide in treating certain diseases (1, 2) . Two hundred patients with epidermophytosis, tinea capitis, tinea favosa, monilia infections, cryptococcosis epidermica, blastomycosis and other mycotic infections have been treated by means of inhalations of ethyl iodide. Many of these patients, treated for a period of years with unsatisfactory results by the methods hitherto available, have shown striking improvement and even complete recovery. No reports of the therapeutic use of ethyl iodide by other investigators were available in the literature. The purpose of the present investigation was to study the elimination of ethyl iodide after inhalation in order to establish the optimum dosage and frequency of treatment, and to gain knowledge concerning the mechanism of its action.
AMOUNT OF ETHYL IODIDE RETAINED IN BODY AT THE END OF INHALA-TION PERIOD
The first object of the study was to measure the amount of ethyl iodide remaining in the body at the termination of the inhalation of the ethyl iodide vapor.
The ethyl iodide2 was weighed, or was measured by means of a Curves showing the percentage excretion during successive 12-h:our periods following treatment varied but slightly in all subjects regardless of the dosage. The average rate of iodide excretion expressed as the percentage of the total excreted in the urine is shown in figure 9 .
In a given patient, urinary excretion of iodide ceased after approximately the same time interval regardless of the amount of ethyl iodide inhaled (table 3). The duration of excretion was not altered appreciably by doubling the fluid intake (solid and dotted lines, figure 8 ). That the volume of urine did not affect the rate of excretion In brief, one may conclude that after 1.0 to 3.0 cc. of ethyl iodide are inhaled, an average of 45 per cent is immediately exhaled during treatment, 9 per cent is exhaled during the first 2 hours after treatment and 31 per cent is excreted by the kidneys. This accounts for 85 per cent of the total dose given, the other 15 per cent being excreted in all probability by the intestines, skin, and in the sputum ( fig. 10 ).
DISCUSSION
Frequency and amount of dosage. The action of a drug depends in large part on its concentration within the body. It is consequently 646 desirable. to maintain a high level of concentration of the drug in the body by administering sufficient amounts at appropriate intervals to offset excretion of the substance. Elimination of ethyl iodide takes place through the lungs, the kidneys, the gastro-intestinal tract, and in the sputum. The results of the present investigation demonstrate that a total of 54 per cent of the inhaled ethyl iodide is exhaled during treatment and within the first few hours immediately following treatment. Measurements of the elimination of iodide in the urine after inhalation of ethyl iodide offer important evidence regarding the amount remaining within the body since 68 per cent of the ethyl iodide not exhaled during and immediately following treatment, is excreted as iodide in the urine (table 3) . The rate of excretion is greatest immediately following treatment and decreases rapidly. Approximately 85 per cent of the total urinary iodide is excreted within the first 24 hours and approximately 97 per cent is excreted by the end of 48 hours. This indicates that daily repetition of the dosage is desirable to maintain a high level of iodide within the body; that is to say, a given dose repeated daily will maintain a higher level of concentration than twice that dose given every other day. It should be noted, however, that since 15 per cent or more remains within the body, daily repetition will lead to accumulation and, ultimately to toxic effects. To prevent such an occurrence,the daily dosage could be reduced on each successive day, but practically, the same purpose may be achieved by omitting treatment every third or fourth day. Forty-eight hours will then elapse between two treatments, an interval of time sufficiently great to permit almost complete elimination of the accumulated iodide. The amount of the daily dosage of ethyl iodide must depend largely on the therapeutic results and the absence of toxic effects as observed clinically. Clinical experience up to the present indicates that daily doses of 4 grams are efficacious but further experience is necessary to establish this more precisely. Future communications will give further information regarding this point.
Influence of fluid and food intake on excretion of iodide. The water intake during treatment need not be regulated since the excretion of iodide seems to be independent of the fluid ingested ( fig. 8 ). The influence of diet was not studied since the iodide content of food is so
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small that the effect may be considered unimportant for these purposes. It is probable, that in the presence of toxicity, increased amounts of sodium chloride in the diet will facilitate excretion.
Contraindications to the use of ethyl iodide. Impaired excretory function of the kidney will probably favor retention of iodide and the appearance of toxic effects. We have therefore been particularly careful to avoid treating subjects with evidence of nephritis. The urine of all subjects was examined previous to and following treatment in order to exclude any possible untoward effects on kidney function. No evidence of renal irritation was observed. Ethyl iodide was not administered to any patients with symptoms or signs of thyrotoxicosis.
Mechanism of action of ethyl iodide. The use of ethyl iodide was originally suggested because it is an unstable compound which can be absorbed directly into the arterial circulation and so reach the peripheral tissues in high concentration. Ethyl iodide is only slightly soluble in water so that intravenous administration would be inadvisable. If given intravenously a part of the ethyl iodide would, moreover, be given off immediately by the lungs before it reached the arterial blood. The investigations of Henderson and Haggard (9) , and of Starr and Gamble (10) indicate that more than threequarters of inhaled ethyl iodide is immediately hydrolyzed in the arterial and capillary blood before it reaches the veins. Some of the ethyl iodide, however, passes into the tissues during inhalation and accumulates there in increasing, amounts, as shown by the fact that, after ethyl iodide inhalation is discontinued, venous concentration of ethyl iodide exceeds arterial concentration. The exact changes that occur in the peripheral blood are still obscure. Minute amounts of free iodine may conceivably be liberated. We have taken blood from patients before and after treatment to learn whether the growth of fungi was less in the latter blood but no significant difference was noted. It is of interest to note that a toxic rash which appeared in a few patients receiving repeated large doses of ethyl iodide was first observed in the diseased areas rather than according to the conventional distribution. The fact that ethyl iodide is a lipoid solvent may also explain in part its striking therapeutic efficacy.
Investigations are planned to study the value of ethyl iodide in other 648
